Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current look at the most promising proteomic and glycomic biomarkers of bladder cancer.

Journal of cancer research and clinical oncology - 19 Feb 2024

Harsanyi Stefan, Kianickova Kristina, Katrlik Jaroslav, Danisovic Lubos, Ziaran Stanislav

Abstract excerpt

BACKGROUND: Bladder cancer (BC) belongs to the most frequent cancer types. The diagnostic process is still long and costly, with a high percentage of false-positive or -negative results. Due to the cost and lack of effectiveness, older methods need to be supplemented or replaced by a newer more reliable method. In this regard, proteins and glycoproteins pose high potential. METHODS: We performed an online search...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nuclear Proteins

Share to Phenotype

Share to Proteomics

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 38372785
DOI: 10.1007/s00432-024-05623-7
PMCID: PMC10876723

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current look at the most promising proteomic and glycomic biomarkers of bladder cancer.PMID 38372785Read ↗

Proteomics as a Complementary Technique to Characterize Bladder CancerSemantic proximity Read ↗

Unmasking molecular profiles of bladder cancer.Semantic proximity Read ↗

Integrative Multi-Omics Analysis for the Determination of Non-Muscle Invasive vs. Muscle Invasive Bladder Cancer: A Pilot StudySemantic proximity Read ↗

Proteomics and genomics of urinary bladder cancer.Semantic proximity Read ↗

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read ↗

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Semantic proximity Read ↗

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAsSemantic proximity Read ↗

A systematic review on diagnostic and prognostic biomarkers for bladder cancerSemantic proximity Read ↗

National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.Semantic proximity Read ↗

Non-Invasive Urine-Based Diagnostic Technologies for Early Bladder CancerSemantic proximity Read ↗

A Comprehensive Investigation toward the Indicative Proteins of Bladder Cancer in Urine: From Surveying Cell Secretomes to Verifying Urine ProteinsSemantic proximity Read ↗

Recent Advances in the Diagnosis and Management of Bladder Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.